Editorial: Immune checkpoint inhibitors in renal cell carcinoma

Scott S Tykodi; Renate Pichler

doi:10.3389/fonc.2023.1203463

Editorial: Immune checkpoint inhibitors in renal cell carcinoma

Front Oncol. 2023 Apr 18:13:1203463. doi: 10.3389/fonc.2023.1203463. eCollection 2023.

Authors

Scott S Tykodi¹, Renate Pichler²

Affiliations

¹ Department of Medicine, Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
² Department of Urology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.

No abstract available

Keywords: biomarker; immune checkpoint inhibitor (ICI); immune related adverse event (irAE); immunotherapy; renal cell carcinoma; treatment free survival.

Publication types

Editorial